This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kitamura, Y. Articles by Tanaka, S. Search for Related Content PubMed PubMed Citation Articles by Kitamura, Y. Articles by Tanaka, S.

Immediate Causes of Death in Thyroid Carcinoma: Clinicopathological Analysis of 161 Fatal Cases

Department of Surgery II, Nippon Medical School (Y.K., K.Sh., S.T.), 1–1-5 Sendagi, Bunkyo-ku, Tokyo 113; and the Surgery Branch, Ito Hospital (M.N., K.Su., O.O., T.M., Ku.I., Ko.I.), 4–3-6 Jingumae, Shibuya-ku, Tokyo 150, Japan

Address all correspondence and requests for reprints to: Yutaka Kitamura, M.D., Department of Surgery II, Nippon Medical School, 1–1-5 Sendagi, Bunkyo-ku, Tokyo 113, Japan. E-mail: taka{at}nms.ac.jp

Most patients with thyroid carcinoma have a good prognosis. Due to the small number of fatal cases, it has not been clarified what conditions result in death for patients with thyroid carcinoma. To provide appropriate management for advanced thyroid carcinoma patients, we analyzed causes of death in 161 fatal cases. Clinical characteristics and immediate (final) causes of death based on pathological conditions were analyzed in 62 anaplastic carcinomas and 99 fatal differentiated carcinomas. Single fatal conditions could not be specified in 55 patients. In the remaining 106 patients, respiratory insufficiency (43%) was the most common specific fatal condition, followed by circulatory failure (15%), hemorrhage (15%), and airway obstruction (13%). Respiratory insufficiency due to remarkable pulmonary metastasis replacing lung tissue, massive hemorrhage and airway obstruction due to uncontrolled local tumors, and circulatory failure resulting from compression of the vena cava by extensive mediastinal or sternal metastases were found to be the most important immediate causes of death. Based on this knowledge, several palliative procedures may be worth considering to improve survival and quality of life in patients with advanced thyroid carcinoma.

This article has been cited by other articles:

				T. Yau, C. Y. Lo, R. J. Epstein, A. K. Y. Lam, K. Y. Wan, and B. H. Lang Treatment Outcomes in Anaplastic Thyroid Carcinoma: Survival Improvement in Young Patients With Localized Disease Treated by Combination of Surgery and Radiotherapy Ann. Surg. Oncol., September 1, 2008; 15(9): 2500 - 2505. [Abstract] [Full Text] [PDF]

				K. Sakano, M. Takahashi, M. Mutoh, N. Niho, M. Komiya, H. Sato, T. Tanaka, T. Sugimura, and K. Wakabayashi Enhanced thyroid carcinogenicity of N-nitrosobis(2-oxopropyl)amine in Otsuka Long-Evans Tokushima Fatty rats, a model of type II diabetes mellitus Carcinogenesis, October 1, 2007; 28(10): 2193 - 2198. [Abstract] [Full Text] [PDF]

				E. Brignardello, M. Gallo, I. Baldi, N. Palestini, A. Piovesan, E. Grossi, G. Ciccone, and G. Boccuzzi Anaplastic thyroid carcinoma: clinical outcome of 30 consecutive patients referred to a single institution in the past 5 years Eur. J. Endocrinol., April 1, 2007; 156(4): 425 - 430. [Abstract] [Full Text] [PDF]

				M. G Catalano, N. Fortunati, M. Pugliese, R. Poli, O. Bosco, R. Mastrocola, M. Aragno, and G. Boccuzzi Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells. J. Endocrinol., November 1, 2006; 191(2): 465 - 472. [Abstract] [Full Text] [PDF]

				C. Saez, M. A. Martinez-Brocca, C. Castilla, A. Soto, E. Navarro, M. Tortolero, J. A. Pintor-Toro, and M. A. Japon Prognostic Significance of Human Pituitary Tumor-Transforming Gene Immunohistochemical Expression in Differentiated Thyroid Cancer J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1404 - 1409. [Abstract] [Full Text] [PDF]

				C. F. A. Eustatia-Rutten, E. P. M. Corssmit, N. R. Biermasz, A. M. Pereira, J. A. Romijn, and J. W. Smit Survival and Death Causes in Differentiated Thyroid Carcinoma J. Clin. Endocrinol. Metab., January 1, 2006; 91(1): 313 - 319. [Abstract] [Full Text] [PDF]

				S. B. Bravo, M. E.R. Garcia-Rendueles, R. Seoane, V. Dosil, J. Cameselle-Teijeiro, L. Lopez-Lazaro, J. Zalvide, F. Barreiro, C. M. Pombo, and C. V. Alvarez Plitidepsin Has a Cytostatic Effect in Human Undifferentiated (Anaplastic) Thyroid Carcinoma Clin. Cancer Res., November 1, 2005; 11(21): 7664 - 7673. [Abstract] [Full Text] [PDF]

				A. Rouxel, G. Hejblum, M.-O. Bernier, P.-Y. Boelle, F. Menegaux, G. Mansour, C. Hoang, A. Aurengo, and L. Leenhardt Prognostic Factors Associated with the Survival of Patients Developing Loco-Regional Recurrences of Differentiated Thyroid Carcinomas J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5362 - 5368. [Abstract] [Full Text] [PDF]

				E. L. Mazzaferri and R. T. Kloos Is Diagnostic Iodine-131 Scanning with Recombinant Human TSH Useful in the Follow-Up of Differentiated Thyroid Cancer after Thyroid Ablation? J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1490 - 1498. [Abstract] [Full Text] [PDF]

				Y. Kitamura, K. Shimizu, K. Ito, S. Tanaka, and M. Emi Allelotyping of Follicular Thyroid Carcinoma: Frequent Allelic Losses in Chromosome Arms 7q, 11p, and 22q J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4268 - 4272. [Abstract] [Full Text] [PDF]

				E. L. Mazzaferri and R. T. Kloos Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1447 - 1463. [Full Text]